|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Aarhus, The Water and Salt Research Center, DK-8000, Aarhus C, Denmark; University of Aarhus, Institute of Experimental Clinical Research, DK-8000, Aarhus C, Denmark
2 University of Aarhus, The Water and Salt Research Center, DK-8000, Aarhus C, Denmark
3 Department of Physiology, School of Medicine, Dongguk University, Kyungju 780-714, Korea, Republic of
4 National Institutes of Health, Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA
5 University of Aarhus, The Water and Salt Research Center, DK-8000, Aarhus C, Denmark; University of Aarhus, Institute of Experimental Clinical Research, DK-8000, Aarhus C, Denmark; Department of Clinical Physiology, Aarhus University Hospital-Skejby, DK-8200, Aarhus N, Denmark
* To whom correspondence should be addressed. E-mail: jf{at}iekf.au.dk.
Urinary tract obstruction impairs urinary concentrating capacity and reabsorption of sodium. To clarify the molecular mechanisms of these defects, expression levels of renal sodium transporters were examined in rats with 24 h bilateral ureteral obstruction (BUO) or at day 3 or 14 after release of BUO (BUO-R). BUO resulted in downregulation of type 3 Na+/H+ exchanger (NHE3) to 41 ± 14%, type 2 Na-Pi cotransporter (NaPi-2) to 26 ± 6%, Na,K-ATPase to 67 ± 8%, type1 bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1) to 20 ± 7%, and thiazide-sensitive cotransporter (TSC) to 37 ± 9%. Immunocytochemistry confirmed downregulation of NHE3, Na,H-ATPase, NaPi-2, BSC-1, and TSC. Consistent with this downregulation, BUO-R was associated with polyuria, reduced urine osmolality, and increased urinary sodium and phosphate excretion. BUO-R for 3 days caused a persistant downregulation of NHE3 to 53 ± 10%, NaPi-2 to 57 ± 9%, Na,K-ATPase to 62 ± 8%, BSC-1 to 50 ± 12%, and TSC to 56 ± 16%, which was associated with a marked reduction in the net renal reabsorption of sodium (616 ± 54 vs. 944 ± 24 µmol/min/kg; p<0.05) and phosphate (6.3 ± 0.9 vs. 13.1 ± 0.4 µmol/min/kg; p<0.05) demonstrating a defect in renal sodium and phosphate reabsorption capacity. Moreover, downregulation of Na,K-ATPase and TSC persisted in BUO-R for 14 days, whereas NHE3, NaPi-2, and BSC-1 were normalized to control levels. In conclusion, downregulation of renal Na transporters in rats with BUO and release of BUO is likely to contribute to the associated urinary concentrating defect, increased urinary sodium excretion and post-obstructive polyuria.
This article has been cited by other articles:
![]() |
G. Wang, C. Li, S. W. Kim, T. Ring, J. Wen, J. C. Djurhuus, W. Wang, S. Nielsen, and J. Frokiaer Ureter obstruction alters expression of renal acid-base transport proteins in rat kidney Am J Physiol Renal Physiol, August 1, 2008; 295(2): F497 - F506. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, W. Wang, R. Norregaard, M. A. Knepper, S. Nielsen, and J. Frokiaer Altered expression of epithelial sodium channel in rats with bilateral or unilateral ureteral obstruction Am J Physiol Renal Physiol, July 1, 2007; 293(1): F333 - F341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Norregaard, B. L. Jensen, S. O. Topcu, M. Diget, H. Schweer, M. A. Knepper, S. Nielsen, and J. Frokiaer COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1322 - F1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Topcu, M. Pedersen, R. Norregaard, G. Wang, M. Knepper, J. C. Djurhuus, S. Nielsen, T. M. Jorgensen, and J. Frokiaer Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction Am J Physiol Renal Physiol, February 1, 2007; 292(2): F736 - F748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Jensen, C. Li, H. A. Praetorius, R. Norregaard, S. Frische, M. A. Knepper, S. Nielsen, and J. Frokiaer Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1021 - F1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Y. Shi, W. Wang, C. Sardeli, T.-H. Kwon, K. Thomsen, T. Jonassen, J. C. Djurhuus, M. A. Knepper, S. Nielsen, et al. {alpha}-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction Am J Physiol Renal Physiol, February 1, 2006; 290(2): F384 - F396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Cochrane, M. M. Kett, C. S. Samuel, N. V. Campanale, W. P. Anderson, D. A. Hume, M. H. Little, J. F. Bertram, and S. D. Ricardo Renal Structural and Functional Repair in a Mouse Model of Reversal of Ureteral Obstruction J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3623 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Norregaard, B. L. Jensen, C. Li, W. Wang, M. A. Knepper, S. Nielsen, and J. Frokiaer COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction Am J Physiol Renal Physiol, August 1, 2005; 289(2): F322 - F333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, J. D. Klein, W. Wang, M. A. Knepper, S. Nielsen, J. M. Sands, and J. Frokiaer Altered expression of urea transporters in response to ureteral obstruction Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1154 - F1162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |